About Index Trending news
Analyze
Top 50 Pricing
CytomX Therapeutics

CytomX Therapeutics

Work at CytomX Therapeutics? Add yourself to this profile

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

Elsewhere

Alexa global traffic share

06 Jan 2015
$20,000,000
Venture capital (Series C)
Canaan Partners, Roche Venture Fund, Third Rock Ventures, +1
31 Jul 2012
$11,000,000
Venture capital (Series B)
03 Mar 2010
$2,500,000
Convertible Note
Mike Panesis